Defining human mesenchymal stem cell efficacy in vivo

[1]  S. Randell,et al.  Lung stem cell update: promise and controversy. , 2016, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[2]  Arthur S Slutsky,et al.  Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. , 2010, American journal of respiratory and critical care medicine.

[3]  A. Keane-Myers,et al.  Bone marrow stromal cells use TGF-β to suppress allergic responses in a mouse model of ragweed-induced asthma , 2010, Proceedings of the National Academy of Sciences.

[4]  V. Goldberg,et al.  Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. , 2010, Tissue engineering. Part A.

[5]  Ron Y. Pinter,et al.  Translation towards personalized medicine in Multiple Sclerosis , 2008, Journal of the Neurological Sciences.

[6]  S. Badylak,et al.  A perivascular origin for mesenchymal stem cells in multiple human organs. , 2008, Cell stem cell.

[7]  Arnold I Caplan,et al.  All MSCs are pericytes? , 2008, Cell stem cell.

[8]  N. Nardi,et al.  In Search of the In Vivo Identity of Mesenchymal Stem Cells , 2008, Stem cells.

[9]  C. Farver,et al.  Peroxisome Proliferator-Activated Receptor-γ Regulates the Expression of Alveolar Macrophage Macrophage Colony-Stimulating Factor , 2008, The Journal of Immunology.

[10]  G. Dini,et al.  Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study , 2008, The Lancet.

[11]  Giselle Chamberlain,et al.  Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for Homing , 2007, Stem cells.

[12]  O. Ringdén,et al.  Immunomodulation by mesenchymal stem cells and clinical experience , 2007, Journal of internal medicine.

[13]  N. Wulffraat,et al.  Immunomodulatory properties of mesenchymal stem cells: a review based on an interdisciplinary meeting held at the Kennedy Institute of Rheumatology Division, London, UK, 31 October 2005 , 2007, Arthritis research & therapy.

[14]  Arnold I Caplan,et al.  Isolation of human marrow-derived mesenchymal stem cells. , 2006, Experimental hematology.

[15]  A. Caplan,et al.  Mesenchymal stem cells as trophic mediators , 2006, Journal of cellular biochemistry.

[16]  P. Charbord,et al.  The concept of mesenchymal stem cells. , 2006, Regenerative medicine.

[17]  A. Braun,et al.  Animal models of asthma: innovative methods of lung research and new pharmacological targets. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.

[18]  P. Pouliot,et al.  Antigen sensitization modulates alveolar macrophage functions in an asthma model. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[19]  G. Walsh.  Novel therapies for asthma--advances and problems. , 2005, Current pharmaceutical design.

[20]  B. Barna,et al.  Multiplexed Particle-Based Anti-Granulocyte Macrophage Colony Stimulating Factor Assay Used as Pulmonary Diagnostic Test , 2005, Clinical Diagnostic Laboratory Immunology.

[21]  V. Goldberg,et al.  FGF‐2 enhances the mitotic and chondrogenic potentials of human adult bone marrow‐derived mesenchymal stem cells , 2005, Journal of cellular physiology.

[22]  J. Ingwall,et al.  Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells , 2005, Nature Medicine.

[23]  Lauren Cohn,et al.  Asthma: mechanisms of disease persistence and progression. , 2004, Annual review of immunology.

[24]  S. Haynesworth,et al.  Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation , 2004, Bone Marrow Transplantation.

[25]  K. Wilson,et al.  Immunomodulatory cytokines in asthmatic inflammation. , 2003, Cytokine & growth factor reviews.

[26]  Naftali Kaminski,et al.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Ohta,et al.  Attenuation of airway hyperresponsiveness in a murine asthma model by neutralization of granulocyte-macrophage colony-stimulating factor (GM-CSF). , 2002, Cellular immunology.

[28]  S. Bruder,et al.  Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. , 2001, Trends in molecular medicine.

[29]  A. Caplan,et al.  The Dynamic in vivo Distribution of Bone Marrow-Derived Mesenchymal Stem Cells after Infusion , 2001, Cells Tissues Organs.

[30]  O. Koç,et al.  Mesenchymal stem cells: heading into the clinic , 2001, Bone Marrow Transplantation.

[31]  A. Caplan,et al.  Dilution of human mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis , 2000, Developmental dynamics : an official publication of the American Association of Anatomists.

[32]  M. Konstan,et al.  IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. , 1999, American journal of respiratory and critical care medicine.

[33]  P. Watkins,et al.  Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases. , 1999, Experimental hematology.

[34]  A. Caplan,et al.  A Quadripotential Mesenchymal Progenitor Cell Isolated from the Marrow of an Adult Mouse , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[36]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[37]  A. Caplan,et al.  In vivo osteogenesis assay: a rapid method for quantitative analysis. , 1998, Biomaterials.

[38]  G. Chrousos,et al.  Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor β , 1997, The Journal of experimental medicine.

[39]  J. Allay,et al.  LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors. , 1997, Human gene therapy.

[40]  Scott P. Bruder,et al.  Human and animal mesenchymal progenitor cells from bone marrow: Identification of serum for optimal selection and proliferation , 1996, In Vitro Cellular & Developmental Biology - Animal.

[41]  A. Caplan,et al.  Differentiation potential of conditionally immortalized mesenchymal progenitor cells from adult marrow of a H‐2Kb‐tsA58 transgenic mouse , 1996, Journal of cellular physiology.

[42]  A I Caplan,et al.  Cytokine expression by human marrow‐derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL‐1α , 1996, Journal of cellular physiology.

[43]  A. Caplan,et al.  Osteogenesis in Marrow-Derived Mesenchymal Cell Porous Ceramic Composites Transplanted Subcutaneously: Effect of Fibronectin and Laminin on Cell Retention and Rate of Osteogenic Expression , 1992, Cell transplantation.

[44]  V. Goldberg,et al.  The origin of bone formed in composite grafts of porous calcium phosphate ceramic loaded with marrow cells. , 1991, Clinical orthopaedics and related research.

[45]  M. Belvisi,et al.  New Advances and Potential Therapies for the Treatment of Asthma , 2012, BioDrugs.

[46]  M. Pittenger,et al.  Mesenchymal stem cells from adult bone marrow. , 2008, Methods in molecular biology.

[47]  M. Kassem,et al.  Human mesenchymal stem cells: from basic biology to clinical applications , 2008, Gene Therapy.

[48]  D. Prockop,et al.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. , 2006, Cytotherapy.

[49]  M. Chopp,et al.  Transplantation of bone marrow stromal cells for treatment of central nervous system diseases. , 2006, Advances in experimental medicine and biology.

[50]  J. Welter,et al.  Generation of pluripotent stem cells and their differentiation to the chondrocytic phenotype. , 2004, Methods in molecular medicine.

[51]  S. Gerson,et al.  Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[52]  A. Caplan,et al.  Analysis of the developmental potential of conditionally immortal marrow-derived mesenchymal progenitor cells isolated from the H-2Kb-tsA58 transgenic mouse. , 1996, Connective tissue research.

[53]  A. Caplan,et al.  Porous ceramic vehicles for rat-marrow-derived (Rattus norvegicus) osteogenic cell delivery: effects of pre-treatment with fibronectin or laminin. , 1993, The Journal of oral implantology.

[54]  A. Caplan,et al.  Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. , 1992, Bone.